General and Administrative Expense of KALA BIO, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
KALA BIO, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • KALA BIO, Inc. General and Administrative Expense for the quarter ending 30 Sep 2025 was $4,534,000, a 3% increase year-over-year.
  • KALA BIO, Inc. General and Administrative Expense for the twelve months ending 30 Sep 2025 was $17,971,000, a 4.2% decline year-over-year.
  • KALA BIO, Inc. annual General and Administrative Expense for 2024 was $18,340,000, a 11% decline from 2023.
  • KALA BIO, Inc. annual General and Administrative Expense for 2023 was $20,567,000.
  • KALA BIO, Inc. annual General and Administrative Expense for 2017 was $10,867,000, a 42% increase from 2016.
Source SEC data
View on sec.gov
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)

KALA BIO, Inc. Quarterly General and Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $17,971,000 $4,534,000 +$134,000 +3% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $17,837,000 $4,643,000 +$326,000 +7.6% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $17,511,000 $4,593,000 -$829,000 -15% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $18,340,000 $4,201,000 -$422,000 -9.1% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $18,762,000 $4,400,000 -$552,000 -11% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $19,314,000 $4,317,000 -$645,000 -13% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $19,959,000 $5,422,000 -$608,000 -10% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $20,567,000 $4,623,000 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $4,952,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $4,962,000 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $6,030,000 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q3 2018 $26,362,000 $8,469,000 +$5,953,000 +237% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $20,409,000 $7,151,000 +$5,592,000 +359% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $14,817,000 $5,482,000 +$3,950,000 +258% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $10,867,000 $5,260,000 01 Oct 2017 31 Dec 2017 10-K 02 Apr 2018 2017 FY
Q3 2017 $2,516,000 +$1,025,000 +69% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $1,559,000 -$2,141,000 -58% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $1,532,000 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q3 2016 $1,491,000 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $3,700,000 01 Apr 2016 30 Jun 2016 10-Q 31 Aug 2017 2017 Q2

KALA BIO, Inc. Annual General and Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $18,340,000 -$2,227,000 -11% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $20,567,000 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2017 $10,867,000 +$3,227,000 +42% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2018 2017 FY
2016 $7,640,000 +$3,031,000 +66% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $4,609,000 01 Jan 2015 31 Dec 2015 10-K 02 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.